Policosanol, Coenzyme Q10, Folic Acid and Berberine: study protocols
4 study groups took Policosanol together with Coenzyme Q10, Folic Acid and Berberine. These are the doses the studies gave. They are not a recommendation.
Fewer than 5 study groups in one unit match, too few to draw the chart.
Commonly used together
4 of 4 study groups took Policosanol, Coenzyme Q10, Folic Acid and Berberine with something else. Shown: what 3 or more different studies gave.
What was given together, not what works together.
| Taken with | Study groups |
|---|---|
| Astaxanthin | 3 |
| Red Yeast Rice | 3 |
4 study groups
| Study | ||||||
|---|---|---|---|---|---|---|
| Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial 2015 · Combination A · Adults aged 18–70 with hypercholesterolemia not requiring statins or statin-intolerant | 10 mg | 2 mg | 200 mcg | 500 mg | 4 weeks | 23 |
| Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial 2019 · Armolipid Plus (AP) · Adults aged 18–70 with metabolic syndrome and left ventricular hypertrophy; men and women | 10 mg | 2 mg | 200 mcg | 500 mg | 24 weeks | 71 |
| Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trial 2014 · Intervention (Armolipid Plus/AP) · Men and women older than 18 years with mild-moderate hypercholesterolemia and elevated LDL-c, candidates for lifestyle intervention without hypolipemic drug treatment | 10 mg | 2 mg | 200 mcg | 500 mg | 12 weeks | 51 |
| Effects of a New Combination of Medical Food on Endothelial Function and Lipid Profile in Dyslipidemic Subjects: A Pilot Randomized Trial 2019 · Nutraceutical B · Adults aged 18–75 with elevated serum cholesterol not requiring statins or statin-intolerant; people with cardiovascular disease and uncontrolled diabetes were excluded. | 10 mg | 2 mg | 200 mcg | 500 mg | 6 weeks | 23 |